{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:05:21Z","timestamp":1761577521728,"version":"build-2065373602"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"DOI":"10.7759\/cureus.95507","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:28:41Z","timestamp":1761575321000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Disease Control With Lenvatinib in Metastatic Malignant Struma Ovarii: A Case Report"],"prefix":"10.7759","author":[{"given":"Ryota","family":"Kawano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Sumikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohki","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Female Genital Tumours. WHO Classification of Tumours, 5th Edition, Volume 4","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board. Female Genital Tumours. WHO Classification of Tumours, 5th Edition, Volume 4. International Agency for Research on Cancer, Lyon, France; 2020."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2011-0092-OA","article-title":"Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior","volume":"136","author":"Shaco-Levy R","year":"2012","unstructured":"Shaco-Levy R, Peng RY, Snyder MJ, et al.. Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior. Arch Pathol Lab Med. 2012, 136:172-8. 10.5858\/arpa.2011-0092-OA","journal-title":"Arch Pathol Lab Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2022.2064021","article-title":"Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii","volume":"39","author":"Taha T","year":"2022","unstructured":"Taha T, Abu-Sini H, Billan S. Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii. Pediatr Hematol Oncol. 2022, 39:769-75. 10.1080\/08880018.2022.2064021","journal-title":"Pediatr Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31818a2b99","article-title":"Histologically bland \"extremely well differentiated\" thyroid carcinomas arising in struma ovarii can recur and metastasize","volume":"28","author":"Garg K","year":"2009","unstructured":"Garg K, Soslow RA, Rivera M, Tuttle MR, Ghossein RA. Histologically bland \"extremely well differentiated\" thyroid carcinomas arising in struma ovarii can recur and metastasize. Int J Gynecol Pathol. 2009, 28:222-30. 10.1097\/PGP.0b013e31818a2b99","journal-title":"Int J Gynecol Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14902","article-title":"Malignant struma ovarii: from case to analysis","volume":"47","author":"Ayhan S","year":"2021","unstructured":"Ayhan S, Kilic F, Ersak B, et al.. Malignant struma ovarii: from case to analysis. J Obstet Gynaecol Res. 2021, 47:3339-51. 10.1111\/jog.14902","journal-title":"J Obstet Gynaecol Res"},{"key":"ref6","article-title":"Endocrine and Neuroendocrine Tumours. WHO Classification of Tumours, 5th Edition, Volume 10","author":"WHO Classification of Tumours Editorial Board","year":"2025","unstructured":"WHO Classification of Tumours Editorial Board. Endocrine and Neuroendocrine Tumours. WHO Classification of Tumours, 5th Edition, Volume 10. International Agency for Research on Cancer, Lyon, France; 2025."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel MD","year":"2025","unstructured":"Ringel MD, Sosa JA, Baloch Z, et al.. 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid. 2025, 35:841-985. 10.1177\/10507256251363120","journal-title":"Thyroid"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1139659","article-title":"Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study","volume":"13","author":"Matsuyama C","year":"2023","unstructured":"Matsuyama C, Enokida T, Ueda Y, et al.. Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study. Front Oncol. 2023, 13:1139659. 10.3389\/fonc.2023.1139659","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14033-y","article-title":"The complex journey of targeting RAS in oncology","volume":"25","author":"Wasiak K","year":"2025","unstructured":"Wasiak K, Ciunowicz D, Kierasi\u0144ska-Ka\u0142ka A, W\u0119gierska M, Pacholczyk M, Rieske P, Stoczy\u0144ska-Fidelus E. The complex journey of targeting RAS in oncology. BMC Cancer. 2025, 25:1053. 10.1186\/s12885-025-14033-y","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf366","article-title":"Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues","author":"Hamidi S","year":"2025","unstructured":"Hamidi S, Maniakas A, Akhave NS, et al.. Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues. J Clin Endocrinol Metab. 2025, dgaf366. 10.1210\/clinem\/dgaf366","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423385-long-term-disease-control-with-lenvatinib-in-metastatic-malignant-struma-ovarii-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:28:41Z","timestamp":1761575321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423385-long-term-disease-control-with-lenvatinib-in-metastatic-malignant-struma-ovarii-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.95507","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}